09 February 2025 : Clinical Research
Inflammatory Biomarkers from Blood Counts as Prognostic Tools in Metastatic Esophageal Cancer
Yonca Yılmaz Ürün
ABF 1, İsmail Beypınar CDE 2*
DOI: 10.12659/MSM.947202
Med Sci Monit 2025; 31:e947202
Table 3 Pretreatment blood and inflammatory parameters.
| Neutrophil n/ul | Lymphocyte n/ul | Monocyte n/ul | Platelets n/ul | SIRI | AISI | |
|---|---|---|---|---|---|---|
| Med | 5000 | 2040 | 580 | 274000 | 1352 | 388 |
| Min | 1760 | 320 | 140 | 102000 | 283 | 56 |
| Max | 14230 | 5300 | 2700 | 636000 | 9787 | 3631 |
| Med | 2.3 | 134 | 8.6 | 3.6 | 680062 | 0.008 |
| Min | 0.86 | 54 | 1 | 0.56 | 171307 | 0.002 |
| Max | 13.98 | 593 | 27 | 13.23 | 5291925 | 0.074 |
| Med – median; Min – minimum; Max – maximum; NLR – neutrophil to lymphocyte; LMR – lymphocyte to monocyte; PLR – platelet to lymphocyte; NLPR – neutrophil platelet lymphocyte; NMR – neutrophile to monocyte ratio; SII – systemic inflammation index; SIRI – systemic inflammatory response index; AISI – aggregate index of systemic inflammation. | ||||||